Ligand validation:7HL1

MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7HL1_MES_A_1003	27%	64%	0.33	0.981	0.76	0.63	-	-	0	0	100%	0.25
5K5M_MES_A_1004	55%	8%	0.211	0.981	3.74	1.05	4	1	1	0	100%	0.25
7HKF_MES_A_1010	33%	28%	0.247	0.926	1.87	1.05	1	1	15	0	100%	0.42
7HKG_MES_A_1003	29%	55%	0.317	0.981	0.93	0.83	-	1	0	0	100%	0.25
7HL6_MES_A_1003	26%	59%	0.337	0.984	0.82	0.77	-	1	0	0	100%	0.25
7HKY_MES_A_1003	25%	55%	0.338	0.979	0.93	0.81	1	1	0	0	100%	0.25
2IUY_MES_B_1355	100%	9%	0.026	0.997	1.73	2.73	1	7	0	0	100%	1
3DPJ_MES_A_192	100%	8%	0.022	0.995	2.2	2.41	1	6	3	0	100%	1
5A0C_MES_B_1002	100%	11%	0.033	0.993	1.84	2.39	3	3	0	0	100%	1
8AJQ_MES_H_201	100%	38%	0.037	0.992	1.52	0.93	1	1	0	0	100%	1
5APG_MES_A_1187	100%	12%	0.044	0.99	1.48	2.57	3	6	0	0	100%	0.9292

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.